Three compounding pharmacies are accused of fraudulently selling unapproved versions of popular weight loss and diabetes drugs.

Novo Nordisk, a Danish pharmaceutical company, separately sued TruLife Pharmacy in Clay County, Brooksville Pharmaceuticals in Hernando County, and Jacksonville’s WellHealth Rx in the Middle District of Florida federal court alleging that the defendants marketed and sold drugs that purport to contain semaglutide but are not FDA-approved.

“What I believe these pharmacies were doing was formulating unapproved versions of the drugs with semaglutide sodium and semaglutide acetate but what’s been approved in the U.S. is actually the base form of semaglutide and there is no basis that semaglutide sodium and semaglutide acetate have any type of therapeutic effects in the body,” said Reuben Saba, vice president of medical and business affairs at Medicure, a pharmaceutical company.

Florida LawTV

Law TV®’s objective is to provide the best possible legal news coverage to the public in a manner that is timely, accurate, clear and easy to understand. We endeavor to remain steadfast to journalistic values and standards excellence. Our mission is to create the finest possible law focused news product available on the Web.

Click Here To Read The Full Article